FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4624611000001108: Olmetec 40mg tablets (Sankyo Pharma UK) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18041901000001114 Olmetec 40mg tablets (Sankyo Pharma UK) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38446501000001119 Olmetec 40mg tablets (Daiichi Sankyo UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olmetec 40mg tablets (Sankyo Pharma UK) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Is a Product containing precisely olmesartan medoxomil 40 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Has excipient Lactose false Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Has active ingredient Olmesartan medoxomil false Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Is a Olmetec true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Has specific active ingredient Olmesartan medoxomil true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Olmetec 40mg tablets (Sankyo Pharma UK) 28 tablet 2 x 14 tablets Is pack of False Olmetec 40mg tablets (Sankyo Pharma UK) Inferred relationship Existential restriction modifier
Olmetec 40mg tablets (Sankyo Pharma UK) 28 tablet 2 x 14 tablets Has AMP True Olmetec 40mg tablets (Sankyo Pharma UK) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start